Compare Albemarle Corp. (ALB) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Albemarle Corp. vs Eli Lilly And Co — how do they compare? Albemarle Corp. trades at $131.06 (market cap $15.27B), while Eli Lilly And Co trades at $1,212 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 70.7× Albemarle Corp.'s market cap, and Albemarle Corp. pays the higher dividend (1.27%). Which is the better fit depends on your goals.
| ALB | LLY | |
|---|---|---|
Market Cap | $15.27B | $1.08T |
Sector | Basic Materials | Health |
52-Week High | $215.62 | $1.24K |
52-Week Low | $72.58 | $639.43 |
Enterprise Value | $17.75B | $1.13T |
Dividend Yield | 1.27% | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
